Letermovir for Secondary Prophylaxis of Cytomegalovirus Infection and Disease after Allogeneic Hematopoietic Cell Transplantation: Results from the French Compassionate Program-Reference-Cited by-同舟云学术

Letermovir for Secondary Prophylaxis of Cytomegalovirus Infection and Disease after Allogeneic Hematopoietic Cell Transplantation: Results from the French Compassionate Program

Published:2020-05 Issue:5 Volume:26 Page:978-984
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Robin Christine,Thiebaut Anne,Alain Sophie^ORCID,Sicre de Fontbrune Flore,Berceanu Ana,D'Aveni Maud,Ceballos Patrice,Redjoul Rabah,Nguyen-Quoc Stéphanie,Bénard Nathalie,Pahlavan-Grumel Golriz,Cordonnier Catherine

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference15 articles.

1. Recent advances in cytomegalovirus: an update on pharmacologic and cellular therapies;Boeckh;Biol Blood Marrow Transplant,2015

2. Cytomegalovirus reactivation is associated with increased risk of late-onset invasive fungal disease after allogeneic hematopoietic stem cell transplantation: a multicenter study in the current era of viral load monitoring;Yong;Biol Blood Marrow Transplant,2017

3. Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation;Marty;N Engl J Med,2017

4. A mortality analysis of letermovir prophylaxis for cytomegalovirus (CMV) in CMV-seropositive recipients of allogeneic hematopoietic-cell transplantation;Ljungman;Clin Infect Dis,2019

5. Economic burden of preemptive treatment of CMV infection after allogeneic stem cell transplantation: a retrospective study of 208 consecutive patients;Robin;BMC Infect Dis,2017

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytomegalovirus in haematopoietic cell transplantation - The troll is still there;Best Practice & Research Clinical Haematology;2024-09

2. UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS.;Mediterranean Journal of Hematology and Infectious Diseases;2024-08-31

3. Antiviral Agents for Preventing Cytomegalovirus Disease in Recipients of Hematopoietic Cell Transplantation;Viruses;2024-08-08

4. Abordagem à Infeção pelo Vírus Citomegálico em Doentes Submetidos a Transplante Alogénico de Progenitores Hematopoiéticos;Acta Médica Portuguesa;2024-07-15

5. Refractory/Resistant Cytomegalovirus Infection in Transplant Recipients: An Update;Viruses;2024-07-05